In silico discovery and validation of potent small-molecule inhibitors targeting the activation function 2 site of human oestrogen receptor α

In silico discovery and validation of potent small-molecule inhibitors targeting the activation function 2 site of human oestrogen receptor α

Bibliographic Details
Main Authors:	Singh, Kriti, Munuganti, Ravi Shashi Nayana, Leblanc, Eric, Lin, Yu Lun, Leung, Euphemia, Lallous, Nada, Butler, Miriam, Cherkasov, Artem, Rennie, Paul S
Format:	Online
Language:	English
Published:	BioMed Central 2015
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4360945/

Similar Items

Targeting Alternative Sites on the Androgen Receptor to Treat Castration-Resistant Prostate Cancer
by: Lallous, Nada, et al.
Published: (2013)

Molecular mechanism(s) of endocrine-disrupting chemicals and their potent oestrogenicity in diverse cells and tissues that express oestrogen receptors
by: Lee, Hye-Rim, et al.
Published: (2013)

Functional analysis of androgen receptor mutations that confer anti-androgen resistance identified in circulating cell-free DNA from prostate cancer patients
by: Lallous, Nada, et al.
Published: (2016)

Review on ''Bioinformatics, Biocomputing and Perl'' by Michael Moorhouse and Paul Barry
by: Cherkasov, Artem
Published: (2004)

Oestrogens and oestrogen receptors in prostate cancer
by: Kowalska, Karolina, et al.
Published: (2016)

In Silico Discovery of Novel Potent Antioxidants on the Basis of Pulvinic Acid and Coumarine Derivatives and Their Experimental Evaluation
by: Martinčič, Rok, et al.
Published: (2015)

Prediction of HLA-A2 binding peptides using Bayesian network
by: Astakhov, Vadim, et al.
Published: (2005)

Effectiveness of student-led objective tutorials in pharmacology teaching to medical students
by: Arora, Kriti, et al.
Published: (2016)

Plasma oestrogens and oestrogen receptors in breast cancer patients.
by: Mason, R. C., et al.
Published: (1985)

Structural characterization of genomes by large scale sequence-structure threading
by: Cherkasov, Artem, et al.
Published: (2004)

An approach to large scale identification of non-obvious structural similarities between proteins
by: Cherkasov, Artem, et al.
Published: (2004)

In silico discovery of human natural antisense transcripts
by: Li, Yuan-Yuan, et al.
Published: (2006)

In Silico Discovery of Aminoacyl-tRNA Synthetase Inhibitors
by: Zhao, Yaxue, et al.
Published: (2014)

In silico pharmacology: drug design and discovery’s gate to the future
by: Noori, Hamid R, et al.
Published: (2013)

The discovery of natalizumab, a potent therapeutic for multiple sclerosis
by: Steinman, Lawrence
Published: (2012)

Discovery of a highly potent glucocorticoid for asthma treatment
by: He, Yuanzheng, et al.
Published: (2015)

QSAR Accelerated Discovery of Potent Ice Recrystallization Inhibitors
by: Briard, Jennie G., et al.
Published: (2016)

In Silico Insight into Potent of Anthocyanin Regulation of FKBP52 to Prevent Alzheimer's Disease
by: Hung, Tzu-Chieh, et al.
Published: (2014)

A potent multivalent vaccine for modulation of immune system in atherosclerosis: an in silico approach
by: Karkhah, Ahmad, et al.
Published: (2016)

The oestrogen paradox: an hypothesis
by: Santen, Richard J
Published: (2007)

Oestrogen and androgen receptors in melanoma.
by: Rümke, P., et al.
Published: (1980)

The role of coactivators in oestrogen action
by: Brown, M, et al.
Published: (2000)

The structural biology of oestrogen metabolism
by: Thomas, Mark P., et al.
Published: (2013)

Multiple Routes to Oestrogen Antagonism
by: Glover, Hilary R., et al.
Published: (2010)

DrugBank: a comprehensive resource for in silico drug discovery and exploration
by: Wishart, David S., et al.
Published: (2006)

Biomarker discovery in heterogeneous tissue samples -taking the in-silico deconfounding approach
by: Repsilber, Dirk, et al.
Published: (2010)

In Silico discovery of transcription factors as potential diagnostic biomarkers of ovarian cancer
by: Kaur, Mandeep, et al.
Published: (2011)

In silico discovery of novel Retinoic Acid Receptor agonist structures
by: Schapira, Matthieu, et al.
Published: (2001)

Alzheimer's disease biomarker discovery using in silico literature mining and clinical validation
by: Greco, Ines, et al.
Published: (2012)

Cloud Infrastructures for In Silico Drug Discovery: Economic and Practical Aspects
by: D'Agostino, Daniele, et al.
Published: (2013)

Discovery of Dihydrochalcone as Potential Lead for Alzheimer’s Disease: In Silico and In Vitro Study
by: Viet, Man Hoang, et al.
Published: (2013)

In silico Discovery of Novel FXa Inhibitors by Pharmacophore Modeling and Molecular Docking
by: Yinglan Pu, et al.
Published: (2017-06-01)

Evolution of In Silico Strategies for Protein-Protein Interaction Drug Discovery
by: Stephani Joy Y. Macalino, et al.
Published: (2018-08-01)

In Silico-Based High-Throughput Screen for Discovery of Novel Combinations for Tuberculosis Treatment
by: Singh, Ragini, et al.
Published: (2015)

In silico prioritization based on coexpression can aid epileptic encephalopathy gene discovery
by: Oliver, Karen L., et al.
Published: (2016)

Discovery of Novel Anti-prion Compounds Using In Silico and In Vitro Approaches
by: Hyeon, Jae Wook, et al.
Published: (2015)

In silico discovery of novel transcription factors regulated by mTOR-pathway activities
by: Jablonska, Agnieszka, et al.
Published: (2014)

In-silico discovery of cancer-specific peptide-HLA complexes for targeted therapy
by: Dhanik, Ankur, et al.
Published: (2016)

Oestrogen receptors in primary breast cancer.
by: Williams, M. R., et al.
Published: (1985)

Oestrogen is bad for patients with breast cancer?
by: Jordan, V Craig, et al.
Published: (2007)